LUXEMBOURG – In a significant move to bolster the collapsing healthcare landscape in Lebanon, the World Health Organization (WHO) and the European Investment Bank (EIB Global) have officially cemented a strategic partnership aimed at long-term public health stabilization. The agreement, signed on 6 March 2025 during the prestigious EIB Group Forum in Luxembourg, mandates a €10 million grant dedicated to rebuilding critical medical infrastructure and providing essential care for the nation’s most vulnerable populations.
The meeting between Dr. Tedros Adhanom Ghebreyesus, Director-General of the WHO, and Thomas Östros, Vice-President of the EIB, marks a pivotal shift from emergency crisis management to the systematic restoration of Lebanon’s public health architecture.
The Core Mandate: Rebuilding a Fragile System
The initiative is designed to address two of the most pressing voids in Lebanon’s current health landscape: the lack of diagnostic integrity and the acute shortage of life-saving medications.
At the center of this project is the re-establishment of Lebanon’s Central Public Health Laboratory. For years, the laboratory has faced systemic neglect due to economic instability, leaving the country vulnerable to epidemiological blind spots. By restoring this facility, the initiative aims to provide the nation with the diagnostic backbone required to monitor disease outbreaks, ensure food and water safety, and uphold national health standards.
Beyond infrastructure, the grant addresses a mounting human crisis. With the Lebanese economy having faced hyperinflation and a currency collapse, the availability of medication for chronic illnesses—such as cardiovascular disease, diabetes, and cancer—has become severely restricted. The project aims to provide direct healthcare support and medication access to over 50,000 individuals, offering a vital lifeline to those whose treatment pathways have been severed by the economic downturn.
Chronology: A Trajectory of Decline and Recovery
To understand the magnitude of this €10 million injection, one must examine the timeline of the healthcare crisis that has plagued Lebanon over the past half-decade.
- 2019: The Economic Catalyst: The onset of a severe financial crisis in Lebanon triggered a rapid devaluation of the national currency, leading to the immediate destabilization of the medical supply chain.
- 2020: The Beirut Port Explosion: The catastrophic blast at the Port of Beirut decimated medical facilities and destroyed critical stockpiles of vaccines and essential drugs, pushing the already strained system to the brink of collapse.
- 2021–2023: The Brain Drain and Supply Crisis: A mass exodus of medical professionals, coupled with a lack of foreign currency to import medicine, resulted in chronic shortages. The Central Public Health Laboratory, essential for infectious disease surveillance, became largely non-functional.
- 2024: Negotiating the Partnership: Recognizing that stop-gap humanitarian aid was no longer sufficient, the WHO and EIB Global began formal negotiations to move toward sustainable institutional support.
- 6 March 2025: The Luxembourg Accord: The formalization of the €10 million grant at the EIB Group Forum represents the first major, structured investment to pivot from emergency aid toward institutional reconstruction.
Supporting Data: The Scale of the Need
The severity of the situation in Lebanon is underscored by data from the WHO’s regional office. Prior to this intervention, the healthcare system was operating at a fraction of its capacity.
The Burden of Chronic Disease
According to health indicators, non-communicable diseases (NCDs) are the leading cause of mortality in Lebanon. Before the crisis, the state provided subsidized medication through the Ministry of Public Health. However, as the budget for such programs evaporated, the out-of-pocket costs for patients spiked by over 400%, effectively pricing the poor and middle class out of the healthcare market.
Infrastructure Deficits
The Central Public Health Laboratory serves as the national reference for microbiology and epidemiology. Its degradation meant that the country was unable to independently verify the quality of imported medicine or perform advanced diagnostic testing for emerging pathogens. The €10 million investment is specifically earmarked for:
- Modernizing Diagnostic Equipment: Replacing outdated machinery with high-throughput sequencing technology.
- Cold Chain Restoration: Ensuring that medication and vaccines, once imported, can be stored at the appropriate temperatures across the country.
- Human Capital Development: Providing training for lab technicians to operate the new infrastructure, effectively stemming the loss of specialized skills to international markets.
Official Responses: Aligning Global and Regional Objectives
During the signing ceremony, the dialogue between the WHO and the EIB underscored a shared commitment to regional stability.
The WHO Perspective
Dr. Tedros Adhanom Ghebreyesus emphasized that healthcare is a fundamental human right that transcends political volatility. "Our partnership with EIB Global is not merely about providing funds; it is about restoring dignity to a population that has been denied basic health security for too long," Dr. Tedros stated. He noted that the initiative aligns with the WHO’s broader mission to strengthen national health systems to reach Universal Health Coverage (UHC).
The EIB Perspective
Thomas Östros, speaking on behalf of the European Investment Bank, highlighted the strategic importance of investing in Lebanon’s social infrastructure. "The EIB is committed to supporting Lebanon’s recovery. By focusing on the Central Public Health Laboratory, we are investing in the country’s long-term resilience against future health crises. This is a targeted intervention that balances immediate human relief with the necessary institutional strengthening required for a modern, functioning state," Östros noted.
Implications: A Model for Future Humanitarian Intervention
This collaboration sets a significant precedent for international development finance. Historically, humanitarian aid has been bifurcated: short-term emergency relief provided by UN agencies, and long-term development lending provided by international banks. This project bridges that divide.
Transitioning to Resilience
By integrating the WHO’s technical expertise with the EIB’s financial oversight and investment capacity, the project demonstrates how "nexus programming"—linking humanitarian aid, development, and peacebuilding—can be effectively operationalized.
The Impact on Chronic Disease Management
For the 50,000 targeted beneficiaries, the impact will be immediate. The provision of medication for diabetes and cardiovascular issues is expected to reduce the incidence of emergency hospitalizations. In a system where the emergency room has become the primary source of care due to the lack of primary, preventative medicine, this shift will drastically reduce the burden on tertiary care facilities.
Strengthening Sovereignty
Perhaps the most profound implication of this grant is the restoration of national diagnostic sovereignty. With a functioning Central Public Health Laboratory, the Lebanese government can once again take the lead in public health surveillance. This reduces reliance on external NGOs to perform basic diagnostic functions, empowering the Ministry of Public Health to steer its own public health agenda based on data rather than estimation.
Conclusion: The Road Ahead
While €10 million is a substantial investment, it serves as a foundational step in a much longer journey toward the complete rehabilitation of Lebanon’s health sector. The success of this initiative will be measured not only by the number of patients served but by the sustainability of the laboratory infrastructure once the project concludes.
As the WHO and EIB Global begin the implementation phase, the international community will be watching closely. This partnership represents a hopeful template for how international financial institutions and global health organizations can cooperate to prevent the collapse of essential services in fragile states. For the people of Lebanon, the signing in Luxembourg is a tangible manifestation of a global commitment to ensuring that, even in the midst of profound crisis, no one is left behind in the pursuit of health and well-being.
About the Partners
- The World Health Organization (WHO): The directing and coordinating authority for health within the United Nations system, responsible for providing leadership on global health matters and shaping the health research agenda.
- EIB Global: The dedicated arm of the European Investment Bank Group for operations outside the European Union, focusing on increasing the impact of international partnerships and development finance.
For more information on the project’s rollout, stakeholders are encouraged to monitor the official communications channels of the EIB and the WHO Regional Office for the Eastern Mediterranean.
About the Author
